Kaposi's sarcoma
MONDO:0005055A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
Also known as: KS, Kaposi sarcoma, Kaposi's sarcoma, Kaposi's sarcoma (disease), Kaposi's sarcoma of anus, Kaposi's sarcoma of central nervous system, Kaposi's sarcoma of esophagus, Kaposi's sarcoma of gastrointestinal sites
2871 clinical trials for this condition and its sub-types, 45 tagged with Kaposi's sarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Kaposi's sarcoma
-
Classic Kaposi sarcoma 3 trials
-
Endemic Kaposi sarcoma 1 trial
-
Iatrogenic Kaposi's sarcoma 1 trial
-
Colorectal Kaposi sarcoma 0 trials
2 sub-types
- Colon Kaposi sarcoma 0 trials
- Rectum Kaposi sarcoma 0 trials
-
Kaposi's sarcoma drug trial halted early – what we know
Disease control Stopped earlyThis phase II trial tested the drug everolimus in 11 people with classic or endemic Kaposi's sarcoma, a rare skin cancer linked to a virus. The goal was to see if the drug could shrink tumors after 6 months. The study was terminated early, so the full results are not available.
Phase 2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Cancer drug lenalidomide tested for HIV-Linked kaposi sarcoma
Disease control Stopped earlyThis phase 2 trial tested the drug lenalidomide in 12 people with HIV who had Kaposi sarcoma, a type of cancer. Participants took lenalidomide pills for 21 days each month. The study aimed to see if the drug could shrink tumors, but it was stopped early, so the results are not co…
Phase 2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Radioactive seeds zapped tumors from the inside — but trial stopped early
Disease control Stopped earlyThis early study tested a device that places radioactive seeds directly into skin, mouth, or soft tissue tumors. The seeds release alpha radiation to kill cancer cells from within. Only 2 people took part before the trial was stopped, so we don't have enough information to know i…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC